The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention called for a pause Tuesday in the use of Johnson & Johnson’s coronavirus vaccine “out of an abundance of caution” due to an “extremely rare” incidence of blood clots.
— U.S. FDA (@US_FDA) April 13, 2021
Six recipients in the U.S. developed a rare disorder involving blood clots about two weeks after vaccination, The New York Times reported. More than 6.8 million doses of the vaccine have been administered in the U.S.
This is a developing story. Please check back for updates.